Navigation Links
Stereotactic Breast Biopsy introduced with Fischer-Giotto Image at American Society of Breast Surgeons course
Date:5/1/2013

CHICAGO, IL (PRWEB) May 01, 2013

Fischer Medical Technologies will work with the educational arm of the American Society of Breast Surgeons (ASBS) by providing the use of the Fischer-Giotto Image for the introductory stereotactic breast biopsy workshop at the upcoming 14th annual ASBS conference. Fischer’s skilled technical staff from the U.S. and Italy will be assisting with the instruction.

The Fischer-Giotto Image is the only prone breast imaging system that uses the same detector during both the mammography exam and the biopsy procedure. This unique feature minimizes the need for additional exposures and dose, while providing superior quality images. The precise correlation of images produced by the dual-use detector provides more confidence, especially in vacuum assisted biopsies of subtle micro-calcifications.

The Fischer-Giotto Image, a FFDM (full-field digital mammography) and stereotactic breast biopsy system, was introduced in the U.S. in 2012. The first installation of the Fischer-Giotto Image was at Boulder Community Hospital, in Boulder, CO, replacing the Fischer Mammotest system. It is receiving enthusiastic reviews from both the physicians and technologists. Additional systems have been installed at Mankato Clinic (MN), Saratoga Hospital (NY) and Derby Family MedCenters (KS).

ASBS’s Stereotactic Breast Biopsy: An Introductory Course is a full-day session geared toward the breast surgeon with little or no prior experience in stereotactic breast biopsy. The course is currently filled to capacity, however, the Fischer-Giotto Image can be seen at the Fischer-Giotto Booth #203, at the ASBS conference, May 1-5, at the Sheraton Chicago Hotel & Towers.

ABOUT FISCHER MEDICAL TECHNOLOGIES
Fischer’s roots go back to 1910, when H.G. Fischer, the oldest manufacturer of X-ray imaging devices in the United States, began its operations in Chicago, IL. Fischer Medical Technologies LLC is based in Broomfield, Colorado and is the successor company to Fischer Imaging. Fischer Medical was formed in 2006 by the original founders of Fischer Imaging following the acquisition of all the assets of Fischer Imaging, including all patents, trademarks, product designs, and 510(k) filings. Fischer’s focus is on developing differentiated technologies to improve imaging systems’ efficiency and effectiveness through innovative and creative designs. Contact info@fischermti.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10680570.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Robert Lowen MD, Expert Bay Area Plastic Surgeon, Announces Cutting-Edge 3-D Crisalix Imaging Technology to Aid Patients in Choosing their Breast Implant Size
2. Patti Flint MD, A Top Female Plastic Surgeon in the Southwest, Is Proud To Offer Cutting-Edge 3D Crisalix Technology to Patients When Selecting Breast Implants
3. Dr. Vasquez at the Connecticut Plastic Surgery Group Now Offers the Unique Crisalix 3D Simulations for Facial Aesthetics and Breast Augmentation
4. QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research
5. The First Dedicated Breast Cancer Cell Line Transfection Reagent
6. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
7. University of Maryland Breast Cancer Research Pioneer Dr. Angela Brodie Appointed Fellow of New American Association for Cancer Research Academy
8. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
9. Positive Clinical Breast Cancer Data Presented for NuView’s Molecular Imaging Biomarker NLS-VPAC1
10. Frost & Sullivan: Modest Growth Projected in the U.S. Breast Imaging Systems Market Amidst Increasing Breast Cancer Prevalence
11. Transition in cell type parallels treatment response, disease progression in breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology ... announced that an Oncologic Drug Advisory Committee of ... to 0 that the benefit/risk of rituximab/hyaluronidase for ... patients in the proposed indications of follicular lymphoma, ... The FDA action date is June 26, 2017. ...
(Date:3/29/2017)... New Canaan, CT (PRWEB) , ... March 29, 2017 , ... ... of antibiotics and hormones in the world’s food supply through enhancement of the gut ... in the round included Connecticut Innovations , New York-based Sustainable Income Capital Management, ...
(Date:3/29/2017)... /PRNewswire/ -  GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") ... risk stratification test for breast cancer, via its ... BreastSentry incorporates a blood-based biomarker test with a sophisticated algorithm ... breast cancer.   ... BreastSentry measures the fasting plasma levels of two ...
(Date:3/28/2017)... ... March 28, 2017 , ... NetDimensions announced today that Scandinavian ... training plan management for consistent implementation of standards and regulatory requirements across SHL ... to help improve and streamline their training and employee development programs, which are ...
Breaking Biology Technology:
(Date:3/1/2017)... -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics ... has resigned, effective March 3, 2017, as co-Chief ... Treasurer of Aware citing a desire to retire.  Mr. ... the Board of Directors of Aware. ... co-President, General Counsel has been named Chief Executive Officer, ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):